Membrane expression of trail receptors DcR1 and DcR2 in the normal endometrium, endometrial atypical hyperplasia and endometrioid endometrial cancer

被引:3
|
作者
Gottwald, L. [1 ,5 ]
Pasz-Walczak, G. [2 ]
Piekarski, J. [3 ]
Szwalski, J. [7 ]
Kubiak, R. [2 ]
Spych, M. [1 ,6 ]
Suzin, J. [4 ]
Tylinski, W. [4 ]
Sek, P. [3 ]
Jeziorski, A. [3 ]
机构
[1] Med Univ Lodz, Dept Radiotherapy, Lodz, Poland
[2] Med Univ Lodz, Dept Pathol, Lodz, Poland
[3] Med Univ Lodz, Dept Surg Oncol, Lodz, Poland
[4] Med Univ Lodz, Dept Gynecol & Gynecol Oncol, Lodz, Poland
[5] Copernicus Mem Hosp, Reg Canc Ctr, Dept Teleradiotherapy, PL-93509 Lodz, Poland
[6] Copernicus Mem Hosp, Reg Canc Ctr, Dept Radiotherapy & Gen Oncol, PL-93509 Lodz, Poland
[7] Olympus Consilio Co Ltd, Histopathol Unit, Lodz, Poland
关键词
DcR1; DcR2; endometrial atypical hyperplasia; endometrial cancer; immunohistochemistry; normal endometrium; TRAIL; APOPTOSIS-INDUCING LIGAND; DECOY RECEPTOR; MEMBER; FAMILY; CELLS;
D O I
10.3109/01443615.2014.889667
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
We aimed to evaluate the membrane expression of DcR1 and DcR2 in the normal endometrium (NE), endometrial atypical hyperplasia (EAH) and endometrioid endometrial cancer (EEC). The study comprised 101 patients: 20 NE, 14 EAH and 67 EEC. Membrane expression of DcR1 and DcR2 was examined and presented as total score (TS). The membrane expression of both DcR1 and DcR2 was more common in EEC than in NE (p < 0.001; p < 0.001). A strong correlation was found between type of endometrial tissue (NE/EAH/EEC) and the TS of DcR1 (p = 0.001) and DcR2 (p = 0.001). In EEC, the TS of DcR1 and DcR2 was not related to grading and survival. The TS of DcR1 negatively correlated with staging (p = 0.018), but DcR2 did not. The membrane expression of decoy receptors for TRAIL DcR1 and DcR2 is greater in NE than EEC. In EEC patients, membrane expression of DcR1 and DcR2 are not independent predictors of survival.
引用
下载
收藏
页码:346 / 349
页数:4
相关论文
共 50 条
  • [41] Expression and localization of progesterone receptor membrane component 1 and 2 in normal and malignant endometrial cells
    Kavandi, Leyla
    Ivanova, Vessela S.
    Huyen Nguyen
    Syed, Vigar
    CANCER RESEARCH, 2011, 71
  • [42] Loss of expression of MLH1, MSH2, MSH6, and PTEN related to endometrial cancer in 68 patients with endometrial hyperplasia
    Orbo, A
    Nilsen, MN
    Arnes, MS
    Pettersen, I
    Larsen, K
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2003, 22 (02) : 141 - 148
  • [43] Tissue microarray immunohistochemical expression analysis of mismatch repair (hMLH1 and hMSH2 genes) in endometrial carcinoma and atypical endometrial hyperplasia:: Relationship with microsatellite instability
    Hardisson, D
    Moreno-Bueno, G
    Sánchez, L
    Sarrió, D
    Suárez, A
    Calero, F
    Palacios, J
    MODERN PATHOLOGY, 2003, 16 (11) : 1148 - 1158
  • [44] FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?
    Papadia, Andrea
    Gasparri, Maria Luisa
    Siegenthaler, Franziska
    Imboden, Sara
    Mohr, Stefan
    Mueller, Michael D.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (03) : 491 - 497
  • [45] FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?
    Andrea Papadia
    Maria Luisa Gasparri
    Franziska Siegenthaler
    Sara Imboden
    Stefan Mohr
    Michael D. Mueller
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 491 - 497
  • [46] Cancer history and loss of MSH2 and MLH1 protein expression in patients with endometrial hyperplasia
    Maruyama, A
    Saito, T
    Hachitanda, Y
    Tsukamoto, N
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (03) : 352 - 360
  • [47] Distribution of basement membrane anchoring molecules in normal and transformed endometrium: Altered expression of laminin γ2 chain and collagen type XVII in endometrial adenocarcinomas
    Marko Määttä
    Sirpa Salo
    Kaisa Tasanen
    Ylermi Soini
    Annikki Liakka
    Leena Bruckner-Tuderman
    Helena Autio-Harmainen
    Journal of Molecular Histology, 2004, 35 : 715 - 722
  • [48] Distribution of basement membrane anchoring molecules in normal and transformed endometrium:: Altered expression of laminin γ2 chain and collagen type XVII in endometrial adenocarcinomas
    Määttä, M
    Salo, S
    Tasanen, K
    Soini, Y
    Liakka, A
    Bruckner-Tuderman, L
    Autio-Harmainen, H
    JOURNAL OF MOLECULAR HISTOLOGY, 2004, 35 (8-9) : 715 - 722
  • [49] Expression Patterns of Cytokeratins (CK7, CK20, CK19, CK AE1/AE3) in Atypical Endometrial Hyperplasia Coexisting with Endometrial Cancer
    Vasilevska, Danuta
    Rudaitis, Vilius
    Lewkowicz, Dorota
    Sirviene, Dominika
    Mickys, Ugnius
    Semczuk, Marek
    Obrzut, Bogdan
    Semczuk, Andrzej
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [50] The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer
    Zannoni, Gian Franco
    Monterossi, Giorgio
    De Stefano, Ilaria
    Gargini, Antonio
    Salerno, Maria Giovanna
    Farulla, Ilaria
    Travaglia, Daniele
    Vellone, Valerio Gaetano
    Scambia, Giovanni
    Gallo, Daniela
    HUMAN PATHOLOGY, 2013, 44 (06) : 1047 - 1054